- MRNA -2.01%
Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing
Yahoo Finance · 4 days ago
Open | 122.59 |
High | 123.25 |
Low | 118.03 |
Mkt Cap | 45.51B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 121.18 |
52 Wk. Low | 62.55 |
52 Wk. High | 170.47 |
Related stocks
American biotechnology company
Moderna, Inc. is a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 167M | 91.00% ▼ |
Net Income | -1.18B | - |
Diluted EPS | -2.87 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$3.17 | - |
Q1 2024 | -$3.35 | -$2.87 |
Q4 2023 | -$0.97 | $0.55 |
S&P 500^GSPC | 5,460.48-22.39 (-0.41%) |
Dow 30^DJI | 39,118.86-45.20 (-0.12%) |
Nasdaq^IXIC | 17,732.60-126.08 (-0.71%) |
Bitcoin USDBTC-USD | 60,903.06+1.19% |
8.19-4.21% | |
57.09-0.78% |